GAIN THERAPEUTICS INC (GANX) Stock Institutional Owners
GAIN THERAPEUTICS INC (GANX) is held by 2 institutional investors with a total value of $1.98M. This comprehensive analysis highlights the top institutional holders led by Greenlight Capital, Renaissance Technologies LLC, and others, who collectively account for nearly 100% of the total institutional ownership.Greenlight Capital remains the largest institutional holder with a position worth $1.92M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- GAIN THERAPEUTICS INC (GANX) stock institutional trading activity
- GAIN THERAPEUTICS INC (GANX) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.09% | 588,410 | $1,921,158 |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 17,400 | $56,028 |
Frequently asked questions about GANX
Who owns the most GANX stock?
The largest holders of GANX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GAIN THERAPEUTICS INC (GANX).
Is GANX widely held by superinvestors?
Many widely followed stocks like GANX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GANX is represented among the institutional managers we track.